In conclusion, we have demonstrated that a new mouse model of ERMS driven by the loss of Nf1 and Ink4a/Arf histologically resembles previously-published ERMS models while also displaying unique features, including delayed tumor initiation and sex-dependent growth patterns. This evidence concerns the gene CDKN2A and embryonal rhabdomyosarcoma.